Greedy pharmaceutical CEO Marius strips his research scientist wife Elizabeth of her laboratory credentials, transferring her groundbreaking oncology formula to his glamorous young mistress. For years, Elizabeth damaged her physical health in the laboratory formulating the miracle cancer treatment, only for Marius to lock her out of the corporate campus without a penny. Refusing to be discarded like garbage, Elizabeth partners with premier venture capital funds on Wall Street, founding her own independent biotech powerhouse and filing global priority patents that render Marius's stolen formula legally worthless. On the morning Elizabeth rings the prestigious opening bell at the New York Stock Exchange to announce her company's twenty-billion-dollar valuation, Marius's firm collapses into immediate bankruptcy as creditors swarm his trading floor. Bankrupt, disgraced, and facing financial ruin, Marius rushes to the NYSE podium begging Elizabeth for a licensing lifeline. But will Elizabeth sign his salvation, or let corporate justice take its course?